Kirkland, Goodwin Steer Lilly $7.8B 'Sleep-Wake' Disorder Deal
By Jade Martinez-Pogue · March 31, 2026, 2:07 PM EDT
Pharmaceutical giant Eli Lilly & Co., advised by Kirkland & Ellis LLP, announced plans Tuesday to acquire daytime sleepiness-focused pharmaceutical company Centessa Pharmaceuticals PLC, led by Goodwin Procter LLP, in a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login